Cargando…

Formyl Peptide Receptor 2 Activation Ameliorates Dermal Fibrosis and Inflammation in Bleomycin-Induced Scleroderma

Systemic sclerosis is a profibrotic autoimmune disease mediated by the dysregulation of extracellular matrix synthesis. Formyl peptide receptor 2 (Fpr2) is a G protein-coupled receptor that modulates inflammation and host defense by regulating the activation of inflammatory cells, such as macrophage...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Gyu Tae, Kwon, Yang Woo, Lee, Tae Wook, Kwon, Seong Gyu, Ko, Hyun-Chang, Kim, Moon Bum, Kim, Jae Ho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733889/ https://www.ncbi.nlm.nih.gov/pubmed/31552041 http://dx.doi.org/10.3389/fimmu.2019.02095

Ejemplares similares

Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma
por: Park, Gyu-Tae, et al.
Publicado: (2021)

A case of bleomycin-induced scleroderma.
por: Kim, K. H., et al.
Publicado: (1996)

Formyl Peptide Receptor 2 Alleviates Hepatic Fibrosis in Liver Cirrhosis by Vascular Remodeling
por: Jun, Ji Hye, et al.
Publicado: (2021)

Scleroderma-like Impairment in the Network of Telocytes/CD34(+) Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis
por: Rosa, Irene, et al.
Publicado: (2021)

TRPA1 as a potential factor and drug target in scleroderma: dermal fibrosis and alternative macrophage activation are attenuated in TRPA1-deficient mice in bleomycin-induced experimental model of scleroderma
por: Mäki-Opas, Ilari, et al.
Publicado: (2023)

Vascular Changes in Bleomycin-Induced Scleroderma
por: Yamamoto, Toshiyuki, et al.
Publicado: (2011)

Abstract 57: Expression Of Markers For Pericytes And Myofibroblasts In Bleomycin-induced Dermal Fibrosis: Potential Role Of Neuropeptide Receptors In A Mouse Model For Scleroderma
por: Ibrahim, Mohamed M., et al.
Publicado: (2017)

Recent advances in stem cell therapeutics and tissue engineering strategies
por: Kwon, Seong Gyu, et al.
Publicado: (2018)

A surgical approach to linear scleroderma using Medpor and dermal fat graft
por: Kim, Keun Tae, et al.
Publicado: (2019)

Dose-response Effects of Bleomycin on Inflammation and Pulmonary Fibrosis in Mice
por: Kim, Soo Nam, et al.
Publicado: (2010)

17,20S(OH)(2)pD Can Prevent the Development of Skin Fibrosis in the Bleomycin-Induced Scleroderma Mouse Model
por: Brown Lobbins, Monica L., et al.
Publicado: (2021)

Mirodenafil ameliorates skin fibrosis in bleomycin-induced mouse model of systemic sclerosis
por: Roh, Jong Seong, et al.
Publicado: (2021)

Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma
por: Park, Jong-Sung, et al.
Publicado: (2019)

Hepatocyte growth factor ameliorates dermal sclerosis in the tight-skin mouse model of scleroderma
por: Iwasaki, Tsuyoshi, et al.
Publicado: (2006)

Pyroptosis executor gasdermin D plays a key role in scleroderma and bleomycin-induced skin fibrosis
por: Yang, Huan, et al.
Publicado: (2022)

Differential activation of polymorphisms of the formyl peptide receptor by formyl peptides
por: Mills, John S.
Publicado: (2007)

Mefunidone Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Han, Yuanyuan, et al.
Publicado: (2021)

Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin
por: Štorkánová, Hana, et al.
Publicado: (2021)

Hyperbaric Oxygen Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Yuan, Yuan, et al.
Publicado: (2021)

A Flowable Placental Formulation Prevents Bleomycin-Induced Dermal Fibrosis in Aged Mice
por: Dhall, Sandeep, et al.
Publicado: (2020)

Connective tissue growth factor is induced in bleomycin-induced skin scleroderma
por: Liu, Shangxi, et al.
Publicado: (2009)

Antifibrotic effects of crocetin in scleroderma fibroblasts and in bleomycin-induced sclerotic mice
por: Song, Yinghua, et al.
Publicado: (2013)

Periostin in Mature Stage Localized Scleroderma
por: Kim, Min-Woo, et al.
Publicado: (2017)

The Herbal Formula JI017 Induces ER Stress via Nox4 in Breast Cancer Cells
por: Kim, Tae Woo, et al.
Publicado: (2021)

Endostatin, an angiogenesis inhibitor, ameliorates bleomycin-induced pulmonary fibrosis in rats
por: Wan, Yun-Yan, et al.
Publicado: (2013)

Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts
por: Tsou, Pei-Suen, et al.
Publicado: (2014)

The anti-microbial peptide SR-0379 stimulates human endothelial progenitor cell-mediated repair of peripheral artery diseases
por: Lee, Tae Wook, et al.
Publicado: (2017)

GSPE Protects against Bleomycin-Induced Pulmonary Fibrosis in Mice via Ameliorating Epithelial Apoptosis through Inhibition of Oxidative Stress
por: Sul, Ok Joo, et al.
Publicado: (2022)

Amelioration of Bleomycin-induced Pulmonary Fibrosis of Rats by an Aldose Reductase Inhibitor, Epalrestat
por: Li, Xianwei, et al.
Publicado: (2015)

Increased hemoglobin–oxygen affinity ameliorates bleomycin‐induced hypoxemia and pulmonary fibrosis
por: Geng, Xin, et al.
Publicado: (2016)

Distal airway stem cells ameliorate bleomycin-induced pulmonary fibrosis in mice
por: Shi, Yun, et al.
Publicado: (2019)

Ameliorative Effects of Arctigenin on Pulmonary Fibrosis Induced by Bleomycin via the Antioxidant Activity
por: Wang, Yueshang, et al.
Publicado: (2022)

Epithelial transglutaminase 2 is needed for T cell interleukin-17 production and subsequent pulmonary inflammation and fibrosis in bleomycin-treated mice
por: Oh, Keunhee, et al.
Publicado: (2011)

Formyl peptide receptor 2 determines sex-specific differences in the progression of nonalcoholic fatty liver disease and steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2022)

Honokiol suppresses formyl peptide-induced human neutrophil activation by blocking formyl peptide receptor 1
por: Liu, Fu-Chao, et al.
Publicado: (2017)

SH003 activates autophagic cell death by activating ATF4 and inhibiting G9a under hypoxia in gastric cancer cells
por: Kim, Tae Woo, et al.
Publicado: (2020)

Prevention of Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice by Paeonol
por: Liu, Meng-Han, et al.
Publicado: (2017)

FOXO4 peptide targets myofibroblast ameliorates bleomycin‐induced pulmonary fibrosis in mice through ECM‐receptor interaction pathway
por: Han, Xiaodan, et al.
Publicado: (2022)

Enhancing natriuretic peptide bioactivity prevents bleomycin-induced pulmonary fibrosis
por: Baliga, Reshma S, et al.
Publicado: (2011)

Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice
por: Ju, Nan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_etku63nljkclel81b1fjr2rjau